健康な成人男性におけるCNTO 3649の単回投与および2型糖尿病患者におけるCNTO 3649の複数回投与の安全性、薬物動態および薬力学に関する研究

基本情報

NCT ID

NCT02224118

ステータス

完了

試験のフェーズ

第1相

試験タイプ

介入

目標被験者数

64

治験依頼者名

Janssen Pharmaceutical K.K.

概要

The purpose of this study is to investigate the safety (adverse events, weight, blood pressure, pulse rate, body temperature, abdominal ultrasonography, standard 12-lead electrocardiography, and laboratory tests) of CNTO 3649 when administered once by subcutaneous injection in healthy adult Japanese men or once a week for 4 weeks in Japanese participants with type 2 diabetes mellitus (disorder in which there is decreased insulin in the body or the body's insulin is not effective, resulting in high blood sugar, increased thirst and urine, and many other side effects).

対象疾患

介入

依頼者（Sponsor）